Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Hospital Practice (1995)|May 1, 2001
Complementary and alternative therapies for rheumatic diseaseS L KolasinskiArthritis and Rheumatism|April 1, 1992
Neuropeptides and inflammation. A somatostatin analog as a selective antagonist of neutrophil activation by substance PS L Kolasinski, K A Haines, E L Siegel, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1993
Chemoattraction of neutrophils by substance P and transforming growth factor-beta 1 is inadequately explained by current models of lipid remodelingK A Haines, S L Kolasinski, B N Cronstein, et al.The Journal of Biological Chemistry|January 15, 1991
Low molecular weight GTP-binding proteins in human neutrophil granule membranesM R Philips, S B Abramson, S L Kolasinski, et al.Proceedings of the National Academy of Sciences of the United States of America|August 1, 1991
Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathwaysJ Reibman, S Meixler, T C Lee, et al.Lupus|May 22, 2013
Clinical presentations and outcomes of systemic lupus erythematosus patients with infection admitted to the intensive care unitB K Han, R Bhatia, P Traisak, et al.Arthritis and Rheumatism|March 4, 2008
The Cutaneous Lupus Erythematosus Disease Activity and Severity Index: expansion for rheumatology and dermatologyM S Krathen, J Dunham, E Gaines, et al.Pageof 1